|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 950 F STREET, NW |
Address2 | SUITE 500 |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | MINNEAPOLIS |
State | MN |
Zip Code | 55432 |
Country | USA |
|
5. Senate ID# 24817-12
|
||||||||
|
6. House ID# 310490000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Peter B. Slone, Vice President of Government Affairs |
Date | 04/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S. 515 - A bill to amend title 35, United States Code, to provide for patent reform - provisions related to changes in the way patents are issued and the governing legal process and how such change could impact innovation by medical device companies.
HR 1260- Patent Reform Act of 2009- A bill to provide process and significant legal reforms to the patent system.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rosemary |
Garza |
|
|
|
Peter |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption.
S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption.
HR 756- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care.
S 660- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care.
HR 3090-Health Equity & Accountability Act of 2009- Provides for the elimination of racial and ethnic health disparities.
HR 1213- SAAAVE Act of 2009- Provides technical corrections to the original legislation which unlinks AAA screening with the Welcome to Medicare Physical Exam and extends the one-time benefit to 65-75 year old at-risk Medicare beneficiaries.
HR 2749- Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions
HR 759- FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions
S 1213 - A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Patient-Centered Outcomes Research Trust Fund, and for other purposes - provisions related to comparative effectiveness research.
S. 1796 - America's Healthy Future Act of 2009 - An original bill to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Contains provisions related to medical device excise tax.
S.1679 - Affordable Health Choices Act - contains provisions related to health care reform.
H.R. 3200, Americas Affordable Health Choices Act of 2009, H.R. 3590, the Patient Protection and Affordable Care Act, and H.R. 3962, The Affordable Health Care for Americans Act, as they relate to the Independent Payment Advisory Commission, Comparative Effectiveness Research, National Device Registry, Pain Care Management, Medicare Prevention Screening Benefits, Medicare Shared Saving Pilots and Physician Payment Disclosure.
H.R. 3590, Patient Protection and Affordable Care Act and H.R. 4872, Health Care and Education Reconciliation Act of 2010 as they relate to device excise tax, comparative effectiveness research, Independent Payment Advisory Board, AAA provisions, prevention and wellness, pain management, health disparity provisions, delivery and payment system reforms, physician-payment disclosure.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Peter |
Slone |
|
|
|
Jessica |
Battaglia |
|
|
|
Rosemary |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIN
16. Specific lobbying issues
Restoring American Financial Stability Act - Provisions related to regulations of over-the-counter derivatives by endusers.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jessica |
Battaglia |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 1213- SAAAVE Act of 2009- Provides technical corrections to the original legislation which unlinks AAA screening from the Welcome to Medicare Physical Exam and extends the one-time benefit to 65-75 year old at-risk Medicare beneficiaries, and other provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rosemary |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
HR 2749- Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rosemary |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to the taxation of foreign earnings of U.S. corporations. HR 3200, Americas Affordable Health Choices Act; HR 3590, The Patient Protection and Affordable Health Care Act; HR 3962, Affordable Health Care for America Act and HR 4872, the Reconciliation Act of 2010, and issues related to the taxation of medical devices. HR 4213, the Tax Extenders Act, as it relates to the research and development tax credit.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jessica |
Battaglia |
|
|
|
Peter |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
H.R. 4016, the Hazardous Material Transportation Safety Act of 2009 - Concerned with the section that relates to the transport of lithium batteries.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rosemary |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |